Barrett Esophagus
144
24
34
61
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
22 trials with published results (15%)
Research Maturity
61 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.6%
11 terminated out of 144 trials
84.7%
-1.8% vs benchmark
1%
2 trials in Phase 3/4
36%
22 of 61 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 61 completed trials
Clinical Trials (144)
Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma
Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial
Obeticholic Acid for Prevention in Barrett's Esophagus
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
Impact of RFA on Esophageal Distensibility and Mucosal Impedance
Trans-Oral Sampling as an Alternative Surveillance of Barrett's Esophagus Pilot
Clinical Utility of WATS3D: A 5-Year Prospective Study
Non-Endoscopic Detection of Barrett's Esophagus Using Methylation Biomarkers on EndoSign® Cell Collection Device Samples
A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
Molecular Assessment for Gastro-Esophageal Cancer
Endoscopic Submucosal Dissection (ESD)
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
Aceto-whitening in the Assessment of Gastrointestinal Neoplasia
The Johns Hopkins Heartburn Center Registry
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus
GCC Agonist Signal in the Small Intestine
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples